A health economic evaluation of the multinational, randomized controlled CONVINCE trial - cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis.
Schouten AEM, Fischer F, Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Canaud B, Hegbrant J, Barth C, Cromm K, Davenport A, Fischer KI, Rose M, Török M, Woodward M, Bots ML, Ardine de Wit G, Frederix GWJ, van der Meulen MP; Convince Scientific Committee.
Schouten AEM, et al. Among authors: fischer f.
Kidney Int. 2025 Jan 21:S0085-2538(25)00068-7. doi: 10.1016/j.kint.2024.12.018. Online ahead of print.
Kidney Int. 2025.
PMID: 39848405